Thermo Fisher Scientific, Inc. (TMO)

Home » Stocks » TMO » Financials » Balance Sheet

Stock Price: $514.85 USD 2.49 (0.49%)

Updated Jan 22, 2021 10:38 AM EST - Market open

• Overview
• Financials
• Statistics
• Profile
• Chart

• Income
• Balance Sheet
• Cash Flow
• Ratios

• Annual
• Quarterly
• Trailing

Balance Sheet (Annual)

Numbers in millions USD. Fiscal year is January-December.

Year		2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001	2000	1999	1998	1997	1996	1995
Cash & Equivalents		2,399	2,103	1,335	786	452	1,344	5,826	806	1,016	917	1,564	1,281	625	667	214	327	196	339	298	506	238	268	594	414	-
Short-Term Investments		-	-	-	-	-	-	4.50	4.30	4.30	8.90	7.10	7.50	14.10	23.80	80.66	185	222	536	744	521	556	1,059	929	1,432	-
Cash & Cash Equivalents		2,399	2,103	1,335	786	452	1,344	5,831	810	1,021	926	1,571	1,288	639	691	295	512	418	875	1,042	1,027	793	1,327	1,523	1,846	0.00
Cash Growth		14.08%	57.53%	69.85%	73.86%	-66.35%	-76.96%	619.9%	-20.64%	10.22%	-41.06%	21.99%	101.5%	-7.52%	134.32%	-42.41%	22.48%	-52.23%	-15.97%	1.46%	29.43%	-40.23%	-12.83%	-17.53%	-	-
Receivables		4,349	4,136	3,879	3,049	2,545	2,474	1,942	1,805	1,764	1,474	1,410	1,478	1,450	1,393	560	470	420	430	411	450	553	502	867	694	-
Inventory		3,370	3,005	2,971	2,213	1,992	1,860	1,495	1,443	1,330	1,173	1,131	1,171	1,170	1,165	359	337	302	333	337	394	366	331	544	433	-
Other Current Assets		1,775	1,381	1,236	973	753	863	613	777	708	562	419	408	406	411	139	151	255	134	175	595	652	767	161	159	-
Total Current Assets		11,893	10,625	9,421	7,021	5,741	6,540	9,881	4,835	4,822	4,135	4,531	4,346	3,665	3,660	1,354	1,470	1,395	1,772	1,965	2,466	2,364	2,926	3,094	3,132	-
Property, Plant & Equipment		4,749	4,165	4,047	2,578	2,449	2,427	1,767	1,726	1,611	1,360	1,333	1,275	1,267	1,257	281	261	252	273	271	286	316	534	789	704	-
Long-Term Investments		-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	9.36	17.11	6.15	48.16	63.31	94.40	-
Goodwill and Intangibles		39,728	40,325	41,974	35,297	31,586	32,953	19,575	20,279	19,789	14,909	15,320	15,101	15,871	16,037	2,417	1,672	1,507	1,416	1,348	1,379	1,225	1,123	1,692	1,083	-
Other Long-Term Assets		2,011	1,117	1,227	1,012	1,058	933	641	604	611	945	441	368	404	309	200	174	235	191	231	716	1,161	789	157	128	-
Total Long-Term Assets		46,488	45,607	47,248	38,887	35,093	36,312	21,983	22,610	22,012	17,214	17,094	16,744	17,542	17,603	2,898	2,107	1,994	1,880	1,860	2,397	2,708	2,495	2,702	2,009	-
Total Assets		58,381	56,232	56,669	45,908	40,834	42,852	31,863	27,445	26,834	21,349	21,625	21,090	21,207	21,262	4,252	3,577	3,389	3,651	3,825	4,863	5,072	5,421	5,796	5,141	-
Accounts Payable		1,920	1,615	1,428	926	822	821	692	641	612	547	534	540	677	631	153	131	103	112	112	140	135	124	252	204	-
Deferred Revenue		916	809	719	486	318	312	199	197	193	158	140	135	129	121	85.59	77.78	59.06	58.49	48.17	50.34	47.44	47.44	55.00	45.72	-
Current Debt		676	1,271	2,135	1,255	1,052	2,212	988	93.10	1,273	106	118	14.80	149	483	130	15.02	45.98	484	529	103	275	1,869	177	154	-
Other Current Liabilities		2,685	2,452	2,766	2,199	1,954	2,005	1,248	1,162	1,036	899	848	851	947	917	422	355	477	449	453	435	614	-902	609	510	-
Total Current Liabilities		6,197	6,147	7,048	4,866	4,146	5,350	3,126	2,093	3,113	1,710	1,639	1,540	1,902	2,152	792	579	685	1,104	1,142	729	1,073	1,138	1,092	913	-
Long-Term Debt		17,076	17,719	18,873	15,372	11,420	12,352	9,500	7,031	5,755	2,031	2,064	2,003	2,046	2,181	469	212	215	446	720	1,500	1,532	1,992	1,698	1,457	-
Other Long-Term Liabilities		5,433	4,780	5,335	4,130	3,918	4,603	2,382	2,855	2,927	2,247	2,491	2,620	2,772	3,017	198	120	108	71.90	55.37	100	454	954	1,007	1,016	-
Total Long-Term Liabilities		22,509	22,499	24,208	19,502	15,338	16,954	11,881	9,887	8,683	4,279	4,555	4,623	4,818	5,198	667	332	323	517	775	1,600	1,986	2,945	2,706	2,474	-
Total Liabilities		28,706	28,646	31,256	24,368	19,484	22,304	15,007	11,980	11,796	5,988	6,194	6,164	6,719	7,350	1,458	911	1,008	1,621	1,917	2,329	3,058	3,166	3,798	3,387	-
Total Debt		17,752	18,990	21,008	16,627	12,472	14,564	10,487	7,124	7,028	2,137	2,182	2,018	2,195	2,664	599	227	261	930	1,249	1,603	1,807	1,869	1,875	1,611	-
Debt Growth		-6.52%	-9.61%	26.35%	33.31%	-14.36%	38.87%	47.2%	1.37%	228.86%	-2.04%	8.1%	-8.07%	-17.6%	344.91%	163.21%	-12.87%	-71.93%	-25.51%	-22.13%	-11.27%	-3.31%	-0.34%	16.4%	-	-
Common Stock		10,262	11,388	11,502	10,249	11,205	11,426	8,180	7,918	8,721	9,931	10,988	11,572	11,565	11,988	1,162	1,123	1,279	1,248	1,498	1,624	1,027	1,049	999	951	-
Retained Earnings		22,092	18,696	15,914	13,927	12,142	10,407	8,753	7,697	6,716	5,386	4,351	3,501	2,535	1,773	1,604	1,381	1,019	819	510	1,006	1,042	1,217	1,035	795	-
Comprehensive Income		-2,679	-2,498	-2,003	-2,636	-1,997	-1,285	-77.20	-150	-400	43.60	92.00	-146	388	150	27.18	161	83.22	-36.70	-99.29	-96.34	-55.93	-10.87	-35.81	7.90	-
Shareholders' Equity		29,675	27,586	25,413	21,540	21,350	20,548	16,856	15,465	15,038	15,361	15,431	14,927	14,488	13,912	2,793	2,666	2,382	2,030	1,908	2,534	2,014	2,255	1,998	1,754	-
Total Liabilities and Equity		58,381	56,232	56,669	45,908	40,834	42,852	31,863	27,445	26,834	21,349	21,625	21,090	21,207	21,262	4,252	3,577	3,389	3,651	3,825	4,863	5,072	5,421	5,796	5,141	0.00
Net Cash / Debt		-15,353	-16,887	-19,673	-15,841	-12,020	-13,221	-4,657	-6,314	-6,007	-1,211	-610	-730	-1,556	-1,973	-304	285	157	-54.59	-207	-577	-1,014	-542	-353	235	-
Net Cash / Debt Growth		-9.08%	-14.16%	24.19%	31.79%	-9.08%	183.90%	-26.25%	5.11%	396.03%	98.44%	-16.40%	-53.08%	-21.13%	549.42%	-	81.21%	-	-73.58%	-64.16%	-43.13%	87.17%	53.58%	-	-	-
Net Cash Per Share		-38.38	-42.01	-49.81	-40.10	-30.13	-33.20	-12.92	-17.36	-15.78	-3.00	-1.48	-1.75	-3.69	-10.06	-1.88	1.75	0.97	-0.32	-1.14	-3.44	-6.42	-3.35	-2.31	1.66	0.00
Working Capital		5,696	4,478	2,373	2,155	1,595	1,190	6,755	2,742	1,709	2,425	2,892	2,806	1,764	1,507	562	891	710	668	823	1,737	1,292	1,788	2,002	2,219	-
Book Value Per Share		74.19	68.62	64.34	54.53	53.51	51.60	46.78	42.51	39.49	38.09	37.42	35.69	34.37	70.94	17.29	16.34	14.64	12.04	10.57	15.13	12.75	13.93	13.10	12.40	-